Oxford Instruments (LON:OXIG – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Thursday, Marketbeat reports. They currently have a GBX 95 ($1.20) target price on the stock. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential downside of 95.48% from the stock’s previous close.
Separately, Berenberg Bank decreased their price target on shares of Oxford Instruments from GBX 2,925 ($36.96) to GBX 2,830 ($35.75) and set a “buy” rating for the company in a research note on Tuesday, November 12th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,978.75 ($25.00).
Get Our Latest Report on Oxford Instruments
Oxford Instruments Price Performance
Oxford Instruments Company Profile
Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductor, and healthcare & life science.
Innovation is the driving force behind Oxford Instruments’ growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world.
Featured Stories
- Five stocks we like better than Oxford Instruments
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Why Invest in 5G? How to Invest in 5G Stocks
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- 3 Tickers Leading a Meme Stock Revival
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Oxford Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Instruments and related companies with MarketBeat.com's FREE daily email newsletter.